New Search

If you are not happy with the results below please do another search

Generic filters

50 search results for:


Heartbeat Details Its Commitment to Diversity

As the United States continues to grapple with race issues in the wake of the death of George Floyd, the leaders of Heartbeat have issued their own call for more diversity and inclusion within the healthcare advertising industry, and Heartbeat in particular. The agency recently issued a letter, “Heartbeat’s Commitment to Diversity,” that elaborates on […]


COVID-19 tied to muscle-weakening disease; vaping risk documented

A roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for Covid-19, the illness caused by the virus.


Study Highlights Continued Concern Over Lack of Racial Diversity in Covid-19 Trials

A recent report in the New England Journal of Medicine reveals that the racial and ethnic minority groups most negatively impacted by Covid-19 are also the least represented in these clinical studies to develop vaccines and therapeutics aimed at the disease.


Celleron Gains Worldwide Rights to Shelved Roche Drug

U.K.-based Celleron Therapeutics signed a licensing agreement with Swiss pharma giant Roche for the worldwide rights to the cancer drug emactuzumab, a monoclonal antibody directed against colony-stimulating factor 1 (CSF-1R) expressed on macrophages.